Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although ...

The discovery could serve as a starting point for antiviral strategies. A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the ...

Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even ...

The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...

To try to stay ahead of any future pandemics, scientists at Scripps Research in La Jolla are taking a deeper look into the proteins that coronaviruses depend on to survive. And with their findings, ...

The intricate division of labor within a "crown-shaped" protein complex, which viruses use to replicate their ribonucleic ...